Antiviral Clinical Trial for Long Covid-19

This antiviral clinical trial is testing whether antiviral medications can reduce symptoms and improve quality of life for people living with Long COVID — the condition where symptoms like fatigue, brain fog, headaches, and breathlessness persist for months after a COVID-19 infection. **You may be eligible if...** - You are 18 years or older, any gender - You have an official Long COVID diagnosis from a physician - You had a confirmed or suspected COVID-19 infection at least 6 months ago - You have been experiencing Long COVID symptoms (such as headache, memory problems, fatigue, shortness of breath, or loss of smell/taste) for at least 6 months - You are willing to comply with all study procedures for the duration of the trial **You may NOT be eligible if...** - Your Long COVID symptoms have been present for less than 6 months - You do not have a formal diagnosis of Long COVID from a doctor - You have certain medical conditions or are taking medications that are incompatible with the study drug Talk to your doctor to see if this trial is right for you.